Insight Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Hold
307
0.04% 99
2025
Q4
$330K Buy
307
+13
+4% +$12.4K 0.05% 86
2025
Q3
$224K Sell
294
-94
-24% -$70K 0.07% 108
2025
Q2
$302K Sell
388
-3
-0.8% -$2.33K 0.12% 86
2025
Q1
$323K Sell
391
-19
-5% -$15.8K 0.05% 86
2024
Q4
$316K Sell
410
-398
-49% -$330K 0.04% 82
2024
Q3
$716K Sell
808
-2
-0.2% -$1.8K 0.14% 55
2024
Q2
$734K Buy
810
+525
+184% +$420K 0.13% 46
2024
Q1
$222K Buy
+285
New +$203K 0.04% 83

Other funds holding LLY

Insight Wealth Partners's LLY Position: Q1 2026 in Review

Insight Wealth Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 307 shares worth $283K. The position accounts for 0.04% of the portfolio, ranked #99.

Insight Wealth Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $734K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Insight Wealth Partners held 307 shares of Eli Lilly worth $283K as of Q1 2026.
  • Insight Wealth Partners left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.04% of Insight Wealth Partners's portfolio in Q1 2026, its #99 holding.
  • Insight Wealth Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Insight Wealth Partners's Eli Lilly position peaked at $734K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Insight Wealth Partners's 13F filing for Q1 2026, filed 14 May 2026.